185 related articles for article (PubMed ID: 30354494)
1. 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
Ashek A; Spruijt OA; Harms HJ; Lammertsma AA; Cupitt J; Dubois O; Wharton J; Dabral S; Pullamsetti SS; Huisman MC; Frings V; Boellaard R; de Man FS; Botros L; Jansen S; Vonk Noordegraaf A; Wilkins MR; Bogaard HJ; Zhao L
Circ Cardiovasc Imaging; 2018 Aug; 11(8):e007402. PubMed ID: 30354494
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
Zhao L; Ashek A; Wang L; Fang W; Dabral S; Dubois O; Cupitt J; Pullamsetti SS; Cotroneo E; Jones H; Tomasi G; Nguyen QD; Aboagye EO; El-Bahrawy MA; Barnes G; Howard LS; Gibbs JS; Gsell W; He JG; Wilkins MR
Circulation; 2013 Sep; 128(11):1214-24. PubMed ID: 23900048
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
[TBL] [Abstract][Full Text] [Related]
5. 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.
Benz MR; Czernin J; Allen-Auerbach MS; Dry SM; Sutthiruangwong P; Spick C; Radu C; Weber WA; Tap WD; Eilber FC
Cancer; 2012 Jun; 118(12):3135-44. PubMed ID: 22020872
[TBL] [Abstract][Full Text] [Related]
6. Correlation of 18F-FLT uptake with equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in gastrointestinal cancer.
Kameyama R; Yamamoto Y; Izuishi K; Sano T; Nishiyama Y
Nucl Med Commun; 2011 Jun; 32(6):460-5. PubMed ID: 21423062
[TBL] [Abstract][Full Text] [Related]
7. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
[TBL] [Abstract][Full Text] [Related]
8. Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.
Brockenbrough JS; Souquet T; Morihara JK; Stern JE; Hawes SE; Rasey JS; Leblond A; Wiens LW; Feng Q; Grierson J; Vesselle H
J Nucl Med; 2011 Aug; 52(8):1181-8. PubMed ID: 21764789
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
Sala R; Nguyen QD; Patel CB; Mann D; Steinke JH; Vilar R; Aboagye EO
PLoS One; 2014; 9(7):e101366. PubMed ID: 25003822
[TBL] [Abstract][Full Text] [Related]
10. The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.
Barthel H; Perumal M; Latigo J; He Q; Brady F; Luthra SK; Price PM; Aboagye EO
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):257-63. PubMed ID: 15791434
[TBL] [Abstract][Full Text] [Related]
11. Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents.
Lee EJ; Lee SJ
Oncol Rep; 2013 Feb; 29(2):763-70. PubMed ID: 23232555
[TBL] [Abstract][Full Text] [Related]
12. 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging of thymidine kinase 1 activity after 5-fluorouracil treatment in a mouse tumor model.
Hong IK; Kim SY; Chung JH; Lee SJ; Oh SJ; Lee SJ; Oh J; Ryu JS; Kim TW; Kim DY; Moon DH
Anticancer Res; 2014 Feb; 34(2):759-66. PubMed ID: 24511010
[TBL] [Abstract][Full Text] [Related]
13. In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.
Leyton J; Alao JP; Da Costa M; Stavropoulou AV; Latigo JR; Perumal M; Pillai R; He Q; Atadja P; Lam EW; Workman P; Vigushin DM; Aboagye EO
Cancer Res; 2006 Aug; 66(15):7621-9. PubMed ID: 16885362
[TBL] [Abstract][Full Text] [Related]
14. Resident cell lineages are preserved in pulmonary vascular remodeling.
Crnkovic S; Marsh LM; El Agha E; Voswinckel R; Ghanim B; Klepetko W; Stacher-Priehse E; Olschewski H; Bloch W; Bellusci S; Olschewski A; Kwapiszewska G
J Pathol; 2018 Apr; 244(4):485-498. PubMed ID: 29359814
[TBL] [Abstract][Full Text] [Related]
15. Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.
Krys D; Hamann I; Wuest M; Wuest F
FASEB J; 2019 Dec; 33(12):13837-13851. PubMed ID: 31601121
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment.
Lee HJ; Oh SJ; Lee EJ; Chung JH; Kim Y; Ryu JS; Kim SY; Lee SJ; Moon DH; Kim TW
Cancer Chemother Pharmacol; 2015 May; 75(5):1005-13. PubMed ID: 25776904
[TBL] [Abstract][Full Text] [Related]
17. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
[TBL] [Abstract][Full Text] [Related]
18. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods.
Kenny LM; Vigushin DM; Al-Nahhas A; Osman S; Luthra SK; Shousha S; Coombes RC; Aboagye EO
Cancer Res; 2005 Nov; 65(21):10104-12. PubMed ID: 16267037
[TBL] [Abstract][Full Text] [Related]
19. Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare.
Lee SJ; Kim SY; Chung JH; Oh SJ; Ryu JS; Hong YS; Kim TW; Moon DH
Biochem Pharmacol; 2010 Nov; 80(10):1528-36. PubMed ID: 20723540
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901.
Leyton J; Smith G; Lees M; Perumal M; Nguyen QD; Aigbirhio FI; Golovko O; He Q; Workman P; Aboagye EO
Mol Cancer Ther; 2008 Sep; 7(9):3112-21. PubMed ID: 18790789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
